Institutional filer · SEC 13F · Q4 2025
Seven Fleet Capital Management LP
The reported 13F portfolio of Seven Fleet Capital Management LP (CIK 2092021) - top holdings, how concentrated the book is, and what changed last quarter.
- $69.2M
- Reported book
- 85
- Positions
- #321
- of 360 filers
The verdict
According to SEC Form 13F-HR filings in this corpus, Seven Fleet Capital Management LP ranks #321 of 360 institutional filers by reported book value (largest first), matching the /funds listing. As of Q4 2025 the reported book is $69.2M across 85 positions, a moderately concentrated portfolio.
- $69.2M
- reported 13F value
- 85
- disclosed positions
- 7.6%
- in REVOLUTION MEDICINES I
- #321
- of 360 filers
Top-5 share 26.2% → MID-PACK book (largest five positions vs the rest of the reported 13F book).
According to SEC Form 13F-HR filings in this corpus, Seven Fleet Capital Management LP ranks #321 of 360 institutional filers by reported book value (largest first), matching the /funds listing.
Where Seven Fleet Capital Management LP sits by disclosed position count
Seven Fleet Capital Management LP reports 85 13F positions among 360 filers with holdings (inventory signal, not a quality ranking). Orthogonal to book-value rank.
Seven Fleet Capital Management LP vs all filers by holding count
Where this filer's disclosed position inventory sits among every tracked 13F manager
85 204th of 360 higher than 156 of 360 filers
Filers, banded by disclosed position count
Each bar is a band; taller bars hold more filers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source SEC Form 13F-HR filings · 2026-05-16
Concentration vs. book size among peer filers
Seven Fleet Capital Management LP reports a book ($0.07B) spread across 85 disclosed positions -- more than the 85-position median among similarly sized filers, a broadly diversified book relative to its size.
Reported book value vs. disclosed position count
How 13F filings are computed · All institutional filers · Largest filers by value
SEC Form 13F-HR filing desk
CIK 2092021 · Q4 2025 $69M book
BOOK-LIGHT · POS-FOCUS · CONC-MID · LEAD-MIX · PHOTO-FINISH · TREND-FLAT · FY-SNAPSHOT
- BOOK-LIGHT #321/360
- POS-FOCUS 85 names
- CONC-MID 26% top-5
- LEAD-MIX 7.6% top
- PHOTO-FINISH Stark Wealth
- TREND-FLAT Book steady
- FY-SNAPSHOT Q4 2025
Photo-finish peer on reported book: Stark Wealth Management LLC
Read with: Institutional investor types - Manager type shapes what a 13F book represents — RIAs, hedge funds, and banks file the same form differently.
Reported-book neighbourhood · Seven Fleet Capital Management LP
Nearest tracked filers by aggregate 13F reported book, not a full corpus reprint.
How the reported book breaks down
$69.2M decomposed into the top 5 reported positions (shown below) versus every other disclosed position.
Top Reported Holdings
| # | Security | Value | % of book |
|---|---|---|---|
| 1 | REVOLUTION MEDICINES INC | $5.2M | 7.6% |
| 2 | SOLENO THERAPEUTICS INC | $3.5M | 5.1% |
| 3 | LIQUIDIA CORPORATION | $3.1M | 4.5% |
| 4 | CG ONCOLOGY INC | $3.1M | 4.5% |
| 5 | COMPASS THERAPEUTICS INC | $3.1M | 4.4% |
| 6 | EXELIXIS INC | $3.0M | 4.3% |
| 7 | AXSOME THERAPEUTICS INC | $2.4M | 3.4% |
| 8 | TYRA BIOSCIENCES INC | $2.1M | 3.0% |
| 9 | COGENT BIOSCIENCES INC | $1.9M | 2.8% |
| 10 | TANGO THERAPEUTICS INC | $1.9M | 2.8% |
| 11 | XENCOR INC | $1.7M | 2.4% |
| 12 | PHARVARIS N V | $1.5M | 2.2% |
| 13 | TERNS PHARMACEUTICALS INC | $1.5M | 2.1% |
| 14 | BELITE BIO INC | $1.5M | 2.1% |
| 15 | DYNE THERAPEUTICS INC | $1.4M | 2.0% |
| 16 | NUVALENT INC | $1.3M | 1.8% |
| 17 | ASCENDIS PHARMA A/S | $1.2M | 1.8% |
| 18 | AMICUS THERAPEUTICS INC | $1.2M | 1.7% |
| 19 | VAXCYTE INC | $1.2M | 1.7% |
| 20 | AVALO THERAPEUTICS INC | $1.2M | 1.7% |
| 21 | INHIBIKASE THERAPEUTICS INC | $1.1M | 1.6% |
| 22 | MADRIGAL PHARMACEUTICALS INC | $1.1M | 1.6% |
| 23 | GERON CORP | $1.0M | 1.5% |
| 24 | KRYSTAL BIOTECH INC | $986K | 1.4% |
| 25 | ATHIRA PHARMA INC | $969K | 1.4% |
Latest Quarter Trades · Q4 2025
New positions (85)
Frequently Asked Questions
- How big is Seven Fleet Capital Management LP's 13F portfolio?
- Seven Fleet Capital Management LP reports $69.2M of long US-equity positions across 85 securities as of Q4 2025. This reflects 13F-disclosed holdings only, it is not the firm's total assets under management.
- Where does Seven Fleet Capital Management LP sit among tracked 13F filers?
- According to SEC Form 13F-HR filings in this corpus, Seven Fleet Capital Management LP ranks #321 of 360 institutional filers by reported book value (largest first), matching the /funds listing. The ordinal is recomputed live from filers with reported book value > 0. See /methodology/#corpus-placement.
- What is Seven Fleet Capital Management LP's largest position?
- Seven Fleet Capital Management LP's largest reported position is REVOLUTION MEDICINES INC at $5.2M, about 7.6% of its reported book as of Q4 2025.
- What did Seven Fleet Capital Management LP trade last quarter?
- In its Q4 2025 filing, Seven Fleet Capital Management LP opened 85 new positions. Each change is drawn from a line in the firm's 13F-HR filing and can be verified on SEC EDGAR.
Nationwide filers with similar book size or holding count
Two 13F-derived peer sets for Seven Fleet Capital Management LP: nearest reported book value and nearest holding inventory, not catalog browse links.
Similar reported book
Nearest filers by reported long-equity book ($69.2M here).
Similar holding count
Nearest filers by number of disclosed positions (85 here).
Using this filing
- The rankings sort every tracked filer the same way Seven Fleet Capital Management LP was placed above, so you can see exactly how the rest of the field compares. View the rankings
- Stark Wealth Management LLC reported the nearest book value ($69.9M) this quarter, a useful scale comparison for Seven Fleet Capital Management LP. Compare filers
- 13F-HR reports long US-listed equity positions only, not total AUM, short positions, or non-equity holdings, treat the reported book as a partial picture. Read the methodology
Form 13F-HR discloses long US-listed equity positions of managers with $100M+ qualifying assets, filed within 45 days of period end. Reported value is not total AUM.
Source: U.S. Securities and Exchange Commission (SEC) - EDGAR Form 13F-HR institutional holdings filings · Q4 2025 13F-HR discloses long US-listed equity positions of managers with $100M+ qualifying assets, filed within 45 days of period end. Reported value is not total AUM.
PlainFundData is rendered directly from SEC EDGAR Form 13F-HR institutional holdings filings, no number is typed in by an editor. Filer holdings, changes, and reported book on this page are aggregated live from those 13F-HR extracts. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-05-16.